About Ivan Cheung
Ivan Cheung is a chief executive officer and director at NextPoint Therapeutics.
Ivan Cheung reports to the SEC as a director of 1 public company: Lexicon Pharmaceuticals (LXRX).
Ivan Cheung first appears on SEC filings in 2024.
Experience
This experience comes from Ivan Cheung's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ivan Cheung in the role, so the role may have started earlier or lasted longer.
NextPoint Therapeutics, Inc. Current
Executive officer
CEO & Member of Board of Directors (2024 – Present)
2024 – Present · Cambridge, MA
Develops targeted cancer treatments for patients with solid tumors.
LI
Lexicon Pharmaceuticals, Inc. Current
Member of Board of Directors
2024 – Present · Public company (LXRX)
TP
TPG Current
Senior Advisor
2023 – Present
EU
Eisai US
Strategic Advisor (2008 – 2023)
Deputy President of Global Oncology & Deputy President of Global Neurology (2005 – 2016)
2005 – 2023
BH
Booz Allen Hamilton
Global Health Practice
1998 – 2005
Key Colleagues at Startups
The people Ivan Cheung works with at each company, as listed on that company's latest Form D.
NextPoint Therapeutics, Inc. · Form D, Jul 30, 2026
Paulina Hill
Board Member
R. Jacob Vogelstein
Board Member
JL
Jeffrey Lacey
Secretary & Treasurer
Brian Shuster
Board Member
Detlev Biniszkiewicz
Chairman of the Board
Rakhshita Dhar
Board Member
Axel Hoos
Board Member